INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Cardlytics, Inc. due to alleged violations of federal securities laws, encouraging affected investors to seek legal recourse [2][4]. Group 1: Legal Investigation and Class Action - The law firm is reminding investors of the March 25, 2025 deadline to seek the role of lead plaintiff in a federal securities class action against Cardlytics [2]. - The complaint alleges that Cardlytics and its executives made false or misleading statements regarding consumer engagement and revenue growth, which misled investors [4]. - The firm is also encouraging anyone with information regarding Cardlytics' conduct to come forward, including whistleblowers and former employees [8]. Group 2: Financial Performance and Stock Impact - Cardlytics reported an 8% year-over-year revenue increase for Q1 2024, but this was overshadowed by a 20.2% increase in consumer incentives, leading to a stock price drop of $5.33, or 36.5%, to$ 9.27 per share [5]. - In Q2 2024, Cardlytics experienced a 9% year-over-year revenue decrease to $69.6 million, with a 3% decline in adjusted contribution to$ 36.4 million, resulting in a stock price fall of $3.94, or 57.1%, to$ 2.96 per share [6].